Paul A. Meyers, MD
Pediatric Hematologist-Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
About Me
- Robbins Family Chair in Pediatrics
I am a pediatric oncologist with extensive experience caring for children and young adults with sarcomas. At Memorial Sloan Kettering, we treat more children and young adults with these challenging tumors than anywhere else in the country. I am proud to be part of MSK Kids, a team that takes a comprehensive approach to care. We customize a care plan for each child, with the goal of saving the lives of our young patients.
Read more
Many of our patients are teens and young adults. They are transitioning from childhood dependence on their parents to independent living. We help them maintain their independence in every way during their cancer care while still ensuring that they have the emotional and practical support of their family.
Many of the types of cancer in young adults are quite rare. Very few oncologists have experience treating them. Some young adults have a form of cancer that is seen much more commonly in children and teens. These patients need a team of specialists from multiple medical fields. They can find that level of expertise in the multidisciplinary teams at Memorial Sloan Kettering. Our specialists combine their skills and experience to come up with the most effective therapy for each individual.
I also direct clinical research to develop and assess new therapies for sarcomas. For five years I served as head of the bone sarcoma strategy group for the Children’s Cancer Group. In that role, I directed national clinical trials for osteosarcoma and Ewing sarcoma. I also conducted clinical trials for people with newly diagnosed and recurrent osteosarcoma, Ewing sarcoma, rhabdomyosarcoma, synovial sarcoma, undifferentiated sarcoma, and other unusual tumors that occur in children and young adults. I have much more experience treating these challenging cancers than most doctors.
In addition to caring for patients and doing research, I enjoy teaching. Memorial Sloan Kettering offers one of the most comprehensive training programs in pediatric hematology/oncology in the country. We care for a very large number of patients, and our faculty has many decades of experience. Our trainees see an unparalleled variety of clinical challenges. Fellows also have the benefit of working with faculty at nearby institutions, such as Weill Cornell Medicine and The Rockefeller University.
I have authored or co-authored more than 135 publications about sarcomas. In recognition of my work, I received the Willet E. Whitmore Award for Clinical Excellence from Memorial Sloan Kettering in 1995. I served as president of the Connective Tissue Oncology Society, a leading academic society devoted to the study of sarcomas. I am a member of the National Cancer Institute’s Physician Data Query Pediatric Board.
I am also the founding medical director for Happiness Is Camping, a summer camp for children with cancer. Helping give these kids a respite from the rigors of cancer therapy has been an extraordinary opportunity. To see these children blossom and thrive away from the hospital environment is one of the great joys of my job.
A pediatric hematologist-oncologist is a doctor who treats cancers of the blood in children and adolescents. This doctor is a hematologist (HEE-muh-TAH-loh-jist) who diagnoses and treats blood disorders. They also are an oncologist (cancer doctor).
My Specialties
- Pediatric Oncology
- Osteosarcoma
- Ewing Sarcoma
- Leukemias
- Rhabdomyosarcoma and Other Soft Tissue Developmental Tumors of Childhood
Education
- MD, Mount Sinai School of Medicine
Residencies
- Pediatrics - Mount Sinai Hospital
Awards and Honors
- Castle Connolly: America’s Top Doctor (2024)
- Top Doctors New York Metro Area, Castle Connolly (2023)
- Castle Connolly: America's Top Doctors (2023)
- Castle Connolly: New York Magazine Top Doctors (2002-2018)
Fellowships
- Pediatrics - Cornell Medical Center
- Pediatrics - Memorial Sloan Kettering Cancer Center
Board Certifications
- Pediatrics
- Pediatric Hematology-Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Meyers sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Co-Investigated by Dr. Meyers
- Expanded Access to L-MTP-PE for the Treatment of Osteosarcoma
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Meyers’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Paul A. Meyers discloses the following relationships and financial interests:
-
Margaux Miracle Foundation
Professional Services and Activities (Uncompensated) -
National Cancer Institute
Professional Services and Activities
-
US WorldMeds, LLC.
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].